Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Vinay Bhaskar
Observed name:
V. Bhaskar
Institutions:
University of Calgary,
National Institute of Animal Biotechnology
Observed institutions:
University of California, Los Angeles,
University of Calgary,
National Institute of Animal Biotechnology,
PDL BioPharma (United States)
ORCID:
0000-0001-8696-3374
Observed ORCID:
0000-0001-8696-3374
OpenAlex ID:
A5083606763
Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
2008
·
Kenjiro Sawada
, Anirban K. Mitra
, et al.
·
Cancer Research
·
403
Evidence for Two Distinct G-protein-coupled ADP Receptors Mediating Platelet Activation
1999
·
Laurent Gousset
, Vinay Bhaskar
, et al.
·
Thrombosis and Haemostasis
·
149
PDF
Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent.
2006
·
Vanitha Ramakrishnan
, Vinay Bhaskar
, et al.
·
PubMed
·
128
A Functional Interaction between Dorsal and Components of the Smt3 Conjugation Machinery
2000
·
Vinay Bhaskar
, Scott A. Valentine
, et al.
·
Journal of Biological Chemistry
·
104
A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo
2007
·
Vinay Bhaskar
, Dong Zhang
, et al.
·
Journal of Translational Medicine
·
92
PDF
Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer
2004
·
Daniel E.H. Afar
, Vinay Bhaskar
, et al.
·
Molecular Cancer Therapeutics
·
84
PDF
Conjugation of Smt3 to Dorsal May Potentiate the Drosophila Immune Response
2002
·
Vinay Bhaskar
, Matthew Smith
, et al.
·
Molecular and Cellular Biology
·
79
E-selectin up-regulation allows for targeted drug delivery in prostate cancer.
2003
·
Vinay Bhaskar
, Debbie A Law
, et al.
·
PubMed
·
78
Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits
2007
·
Vinay Bhaskar
, Melvin Fox
, et al.
·
Investigational New Drugs
·
69
The MADF–BESS domain factor Dip3 potentiates synergistic activation by Dorsal and Twist
2002
·
Vinay Bhaskar
, Albert J. Courey
·
Gene
·
68
Drosophila Ulp1, a Nuclear Pore-associated SUMO Protease, Prevents Accumulation of Cytoplasmic SUMO Conjugates
2004
·
Matthew Smith
, Vinay Bhaskar
, et al.
·
Journal of Biological Chemistry
·
58
Restriction of growth and biofilm formation of ESKAPE pathogens by caprine gut-derived probiotic bacteria
2024
·
Prerna Saini
, Repally Ayyanna
, et al.
·
Frontiers in Microbiology
·
14
PDF
M200, an integrin α5β1 antibody, promotes apoptosis in proliferating endothelial cells
2004
·
V. Ramakrishnan
, V. Bhaskar
, et al.
·
Journal of Clinical Oncology
·
3
M200, a Chimeric Antibody Against Integrin alpha5 beta1, Inhibits Cancer Cell Growth In Vitro
2004
·
Vinay Bhaskar
, Pauline Wales
, et al.
·
Journal of Immunotherapy
·
2
Integrin α5β1 as a Novel Therapeutic Target in Renal Cancer
2009
·
Vanitha Ramakrishnan
, Vinay Bhaskar
, et al.
·
Humana Press eBooks
·
1
Identification and validation of anti-TMEFF2-Auristatin E conjugated antibodies in the treatment of prostate cancer
2004
·
D. A. Law
, D. Afar
, et al.
·
Journal of Clinical Oncology
·
1
Targeting cyclic di-AMP signaling through diadenylate cyclase inhibition reduces methicillin resistance in clinical MRSA isolates
2026
·
Niti Kumari
, Itishree Jali
, et al.
·
Current Research in Microbial Sciences
Supplementary Figures 1-4 from Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
2023
·
Kenjiro Sawada
, Anirban K. Mitra
, et al.
PDF
Data from Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
2023
·
Kenjiro Sawada
, Anirban K. Mitra
, et al.
Data from Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target
2023
·
Kenjiro Sawada
, Anirban K. Mitra
, et al.
384 POSTER Targeting integrin alpha5beta1 on multiple tumour-associated cell types inhibits tumour growth in xenograft models
2007
·
V. Bhaskar
, D. Zhang
, et al.
·
European Journal of Cancer Supplements
M200 (volociximab), a chimeric antibody against integrin alpha5 beta1, inhibits tumor growth by multiple mechanisms
2005
·
Vinay Bhaskar
, Pauline Wales
, et al.
·
Cancer Research
In Vivo Validation of Antibodies Against Ov1, a Novel Ovarian Cancer Target
2004
·
Vinay Bhaskar
, Debbie Law
, et al.
·
Journal of Immunotherapy
Show more works
View as search
Works count:
23
Citation count:
1,333
H-index:
12
I10-index:
12
Year
Topic
Type